Lv4
484 积分 2024-04-17 加入
Oesophageal cancer
7天前
已完结
Single-Cell Analysis of Residual Esophageal Squamous Cell Carcinoma after Neoadjuvant Immunochemotherapy Reveals TFAM-Mediated Immunoregulation in Dendritic Cells
8天前
已完结
Single-cell profiling identifies biomarkers for immunochemotherapy in esophageal squamous cell carcinoma
8天前
已完结
Targeting LTBP2 Derived from Cancer-Associated Fibroblasts Sensitizes Esophageal Squamous Cell Carcinoma to Chemotherapy
8天前
已完结
Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial
1个月前
已完结
Pathologic complete response after neoadjuvant immunochemotherapy: Persistent recurrence risk highlights the need for stratified management
2个月前
已完结
The role of pathological response in predicting the benefit of adjuvant therapy after neoadjuvant chemoimmunotherapy in patients with esophageal cancer
2个月前
已完结
Postoperative MRD status Refines Recurrence Risk Stratification Beyond Pathologic Response After Neoadjuvant Chemoradiotherapy for ESCC
2个月前
已完结
Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer
2个月前
已完结
Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma
2个月前
已完结
皖公网安备34019202002308
